Is it time to buy Contango MicroCap Limited?

There is a secret investing trick your stock broker probably does not want you to know.

It’s a simple trick, but one which could save you hundreds, even thousands of dollars on brokerage while diversifying your portfolio across fast-growing ASX listed companies like Slater & Gordon Limited (ASX: SGH), Mayne Pharma Group Ltd (ASX: MYX), and property growth company Cedar Woods Properties Limited (ASX: CWP).

The “secret”

The “secret” is in fact ASX-listed investment company Contango MicroCap Limited (ASX: CTN), and in my view the many positive features of the company earns it a place in almost every top investing portfolio.

Contango MicroCap runs a diversified portfolio of between 60 and 90 small and micro-cap companies, generally with market capitalisations of up to $350 million. Buying shares in the portfolio means gaining diversification across a wide number of fast-growing businesses in just one transaction.

Trying to buy even 20 of these companies yourself (at $30 brokerage each) would cost $600; and this is money that is far better being put to work to grow. For smaller investors this makes Contango a simple and extremely cost effective way to add diversification.

Impressive track record

Contango MicroCap boasts an impressive track record. After smartly navigating the Global Financial Crisis its investment portfolio performance has averaged 16.9% per annum over the last 10 years.

The value of the company’s investments jumped to $175 million in the 2014 financial year and helped deliver an 8.6 cent per share dividend, or a 7.9% yield at the current share price.

Strong performers

It’s impossible to say that this performance will continue, but a look at some of the companies Contango MicroCap holds in its portfolio suggests the outlook could be promising.

As of 30 September, Mayne Pharma Group Ltd made up 2.4% of the portfolio. The pharmaceutical company has strong growth prospects and is the company I recently mused could be the best value healthcare stock around.

Slater & Gordon, which makes up a further 4.2% of the portfolio, is also impressing investors with its aggressive growth and has seen its share price rise 63% in the last 12 months.

The diversification and growing returns of Contango Microcap make it a valuable addition to any portfolio. However, to get your wealth rocketing you must take the next step with The Motley Fool's brand-new FREE guide, "Your 10 Step Guide to Making $1 Million in the Market". This new, free report contains every detail you need to know now to build your personal fortune! Simply click here to secure your FREE copy.

Motley Fool contributor Regan Pearson does not own shares in any of the companies mentioned in this article.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.